Immutep (IMMP) Retained Earnings (2011 - 2025)
Immutep (IMMP) posted Retained Earnings of -$319.3 million for Q4 2025, down 12.28% on a QoQ basis from -$284.4 million in Q2 2025, and down 20.56% year-over-year from -$402.0 million in Q4 2024.
Immutep (IMMP) Retained Earnings (2011 - 2025) Analysis & Trends
Immutep's Retained Earnings history runs 15 years deep, the most recent figure standing at -$319.3 million for Q4 2025.
- Quarterly Retained Earnings fell 20.56% year-over-year to -$319.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$319.3 million (down 20.56% YoY) and the FY2025 annual result came in at -$284.4 million, down 12.78% from the prior year.
- Retained Earnings was -$319.3 million for Q4 2025 at Immutep, down from -$284.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $26.6 million in Q2 2021 and bottomed at -$319.3 million in Q4 2025.
- A 5-year average of -$171.1 million and a median of -$223.5 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings surged 114.7% — and 2024, when it plunged 1352.34%.
- Immutep's Retained Earnings stood at -$211.9 million in 2021, then gained by 0.59% to -$210.7 million in 2022, then declined by 11.6% to -$235.1 million in 2023, then fell by 12.66% to -$264.9 million in 2024, then fell by 20.56% to -$319.3 million in 2025.
- Business Quant data shows IMMP's Retained Earnings at -$319.3 million in Q4 2025, -$284.4 million in Q2 2025, and -$264.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -622,000.00 |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | -319.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -319.33 Mn |
| Jun 30, 2025 | -284.40 Mn |
| Dec 31, 2024 | -264.87 Mn |
| Jun 30, 2024 | -252.17 Mn |
| Dec 31, 2023 | -235.11 Mn |
| Jun 30, 2023 | 20.14 Mn |
| Dec 31, 2022 | -210.68 Mn |
| Jun 30, 2022 | 20.78 Mn |
| Dec 31, 2021 | -211.93 Mn |
| Jun 30, 2021 | 26.56 Mn |
| Dec 31, 2020 | -213.12 Mn |
| Jun 30, 2020 | -180.70 Mn |
| Dec 31, 2019 | -183.22 Mn |
| Jun 30, 2019 | 45.90 Mn |
| Dec 31, 2018 | -181.19 Mn |
| Jun 30, 2018 | 49.11 Mn |
| Jun 30, 2017 | -174.16 Mn |
| Mar 31, 2017 | -173.30 Mn |
| Jun 30, 2016 | -166.12 Mn |
| Jun 30, 2015 | -124.74 Mn |